Evidence map›Paper›PMID 32803658›Full record

ArticleJournal of neuro-oncology2020

Causes of death in pediatric neuro-oncology: the sickkids experience from 2000 to 2017.

Samuele Renzi, Orli Michaeli, Vijay Ramaswamy, Annie Huang, Derek Stephens, Bryan Maguire, Uri Tabori, Eric Bouffet, Ute Bartels

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Samuele Renzi *Division of Hematology/Oncology, the Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 2M9, Canada.ORCID http://orcid.org/0000-0002-6364-5784
Orli Michaeli *Division of Hematology/Oncology, the Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 2M9, Canada.
Vijay RamaswamyDivision of Hematology/Oncology, the Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 2M9, Canada.
Annie HuangDivision of Hematology/Oncology, the Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 2M9, Canada.
Derek StephensDivision of Statistics, the Hospital for Sick Children, Toronto, Canada.
Bryan MaguireDivision of Statistics, the Hospital for Sick Children, Toronto, Canada.
Uri TaboriDivision of Hematology/Oncology, the Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 2M9, Canada.
Eric BouffetDivision of Hematology/Oncology, the Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 2M9, Canada.
Ute BartelsDivision of Hematology/Oncology, the Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 2M9, Canada. ute.bartels@sickkids.ca.
Hospital for Sick Children · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePrimary benign and malignant central nervous system (CNS) tumors are the most frequent solid tumors in the pediatric age and represent the leading cause of death by cancer in children in high income countries. However, information regarding specific causes of death in this population is still limited. The objective of this work was to investigate mortality in a large cohort of children diagnosed at our institution.

methodsWe identified patients consecutively diagnosed with CNS tumor and treated at a Tertiary Care Canadian Children's Hospital between January 2000 and December 2017. Patient charts were reviewed and different variables such as tumor diagnosis, location, gender, age at diagnosis, age at death and cause of death collected.

resultsOf 1274 patients, 306 (24%) succumbed to their disease. Mortality rate varied significantly according to tumor subtype, ranging from 3.1% in low grade glioma (LGG) to 97.8% in diffuse intrinsic pontine glioma (DIPG). While high grade gliomas (HGG) and DIPG represented only 6.3 and 7.1% of total diagnoses respectively, together they accounted for 49.3% of total deaths (n = 151). Median time from diagnosis to death was 15 months (4 days to 15 years) and shortest for DIPG (11 months). Two hundred and ninety patients (94.8%) died as a result of the primary disease, 4 of treatment-related toxicity, two patients' deaths were unrelated to the primary disease (idiopathic encephalopathy and domestic fire) whereas 10 patients succumbed to a secondary malignancy. Of note, four of these ten patients had a confirmed underlying cancer predisposition syndrome.

conclusionDisease progression is the main cause of death in children with brain tumor, while treatment related mortality is low in this series. Research should continue to focus on improving treatment strategies for patients whose prognosis remains dismal.

Indexed as

AdolescentBrain NeoplasmsCause of DeathChildChild, PreschoolDisease ProgressionFemaleFollow-Up StudiesHumansInfantInfant, NewbornMalePrognosisRetrospective StudiesSurvival RateTime FactorsBrain tumorsCentral nervous system tumorsCNSMortalityPediatric

Identifiers

PMID32803658
OpenAlexW3049570844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.